![Yen Wen Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 30/09/2026
Mr. Yen Wen Yu is a Chief Operating Officer at Disc Medicine, Inc. Mr. Yu was previously employed as a Vice President-Finance & Operations by Qpex Biopharma, Inc. and a VP-Strategic Planning & Corporate Development by The Medicines Co. He received his undergraduate degree from Harvard College and an MBA from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,14 % | 25/08/2026 | 54.324 ( 0,14 % ) | 4 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DISC MEDICINE, INC. | Director de Operaciones | 07/02/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Qpex Biopharma, Inc.
 Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company | Fundador | 01/07/2020 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/07/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
